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Background: Deletions of the gene encoding mediator subcomplex 12 (MED12) in human smooth muscle tumors
rank among the most frequent genomic alterations in human tumors at all. In a minority of these cases, small
deletions are found. In an attempt to delineate key features of the deletions aimed at a better understanding of the
molecular pathogenesis of uterine smooth muscle tumors we have analyzed 70 MED12 deletions including 46 cases
from the literature and 24 own unpublished cases.
Results: The average length of the deletions was 18.7 bp ranging between 2 bp and 43 bp. While in general
multitudes of 3 clearly dominated leaving the transcript in frame, deletions of 21, 24, 30, and 33 nucleotides were
clearly underrepresented. Within the DNA segment affected deletion breakpoints were not randomly distributed.
Most breakpoints clustered within the center of the segment where two peaks of breakpoint clusters could be
distinguished. Interestingly, one of these clusters coincides with the loop of a putative folded non-B DNA structure
whereas a much lower number of breaks noted in the 5′ and 3′ stem of the structure forming an intramolecular
B-helix. The second cluster mainly consisting of 3′ breaks was located in a region downstream adjacent to the stem.
Conclusion: The present study describes for the first time main characteristics of MED12 deletions occurring in
smooth muscle tumors. Interestingly, the non-random distribution of breakpoints within the deletion hotspot
region may point to a role of non-canonical DNA structures for the occurrence of these mutations and the
molecular pathogenesis of uterine smooth muscle tumors, respectively.
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The high prevalence of uterine fibroids (syn.: leiomyomata)
not only makes them the most frequent symptomatic
human tumors at all but also places recurrent mutations in
these benign smooth muscle tumors among the most
predominant mutations during tumorigenesis. Of the
latter, rearrangements of the gene encoding high
mobility AT-hook 2 protein (HMGA2) are accompanied
by chromosomal translocations affecting its locus on* Correspondence: bullerd@uni-bremen.de
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distribution, and reproduction in any mediumchromosome 12 [1] and thus, as a rule, can be detected by
classical cytogenetics. As a molecular consequence,
HMGA2 becomes strongly upregulated [2,3]. Another,
even more frequent type of mutations usually does not
coincide with microscopically visible chromosomal devia-
tions. Quite recently, mutations of mediator subcomplex
12 (MED12), have been described in a majority of fibroids
[4]. They mostly occur in those fibroids not displaying
cytogenetic deviations but can also be associated e.g.
with deletions of the long arm of chromosome 7 or
chromosomal translocations involving 6p21 [5]. It almost
goes without saying that due to the high prevalence of
fibroids MED12 mutations can be considered being thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cluster within a hotspot region in the second exon of the
gene with most of the mutations constituting single base
exchanges within one triplett. Nevertheless, the same region
is also often affected by in frame deletions. We feel that an
in depth analysis of these deletions may contribute to a
better understanding of the molecular pathogenesis of
fibroids. Hence, we have summarized the data on MED12
deletions from the cases published so far as well as from
our own unpublished cases. In summary, a total of 70
smooth muscle tumors with MED12 deletions including
46 cases published previously [4-11] as well as 24 own
unpublished cases have been analyzed.
Results
A total of 70 smooth muscle tumors withMED12 deletions
retrieved from the literature (46 cases), as well as from
further unpublished own cases (24 cases) were analyzed
(Table 1).
In general, these MED12 deletions covered a genomic
region of 72 bp. At its 5’ end the region starts within
intron 1 and ends at position c.166 of exon 2 (Figure 1).
Within that deleted region the size of the individual
deletions strongly varied in size ranging between 2 and
43 bp (Figure 2) with an average length of 18.7 bp. In five
cases the deletions were accompanied by insertions but no
insertions without deletions were observed (cf. Table 1).
As to the lengths of the individual deletions, a strong
preference of multitudes of 3 is noted reflecting the fact
that, as a rule, the deletions are gain of function mutations
leaving the transcript in frame (Figure 3). Most of the
lengths not representing multitudes of 3 were due to a
start of the deletion within intron 1 with a presumed
alteration of the splice site. Among the cases showing
deletions with multitudes of 3 bp deletions of 21, 24, 30,
and 33 bp were clearly underrepresented.
It seems reasonable to assume that the breakpoints are
arranged over the whole region with their frequency more
or less following a normal distribution. Accordingly, they
indeed preferentially occurred in the center of the region.
Nevertheless, surprisingly two peaks clearly became visible
(Figure 4A). The reasons for this bimodal appearance are
not clear but an influence of the local DNA structure is
one of the likely explanations.
Because non-canonical DNA conformations are con-
sidered as being a possible reason for deletions, we have
used the m-fold software as well as the non-B DB search
tool to predict hairpin structures in the part of MED12
affected by the deletions. The non-B DB search tool did
not predict non-B DNA structures for a DNA fragment
of 86 bases extending the border of the affected segment
by seven and six bp, respectively. In contrast, for the
same segment the m-fold software predicted folded
structures. Of these Figure 4B shows the one with thelowest free energy (-10.06 kcal/mol). Located almost in
the center of the region affected by deletions a stem-loop
structure due to a 6 bp inverted repeat exists that also
covers the point mutation hotspot within codon 44 by its
3’stem region. Interestingly, the loop of this central
putative hairpin structure is also a cluster region of
deletion breakpoints. Another cluster with high frequency
of breakpoints is the area downstream of the stem
(Figure 4B) as also reflected by the bimodal distribution of
the breakpoints (c.f. Figure 4A). An in depth analysis
of this structure reveals a strong preference of the
loop region to be affected by 5’ breaks and a preference
of the region downstream of the stem for 3’breaks
(Figure 5A and B).
Discussion
The vast majority of uterine fibroids shows genetic
alterations ranging from gross cytogenetically visible
genomic deviations to point mutations. As to the type of
mutations observed; large genomic deletions of parts of
the long arm of chromosome 7 apparently constitute loss
of function mutations [1] whereas in other cases genomic
rearrangements like those of the HMGA2 locus result in a
gain of function. Another highly frequent type of mutations
of the latter group are those affectingMED12 [4-9,11] that
are likely to constitute the most frequent gene alterations
in human tumors at all. Quite recently, similar mutations
were also observed in leiomyosarcomas and extrauterine
leiomyomas [7,9-11,13] but they seem to be exceptionally
rare in tumors not originating from smooth muscle tissue
[13]. The almost exclusive presence of these mutations in
smooth muscle tumors may point to some tissue specificity
of the hotspot affected. Alternatively, it may reflect merely
a growth advantage of affected cells in smooth muscle
tissue.
In contrast to single base exchanges deletions within and
around the hotspot region are only found in a minority of
roughly 14.5% of the fibroids with MED12 mutations. The
c.130/131 hotspot for base exchanges is flanked by a much
larger region where deletions of highly variable lengths
can occur. These deletions clearly not only allow to
delineate a hypermutable region of the genome but
also represent even one of the most commonly deleted
regions in human tumors known so far. In nearly all cases
of “pure” exonic deletions multitudes of 3 bp had been
removed which likely indicates clonal selection towards
transcripts that remain in frame rather than a preferred
primary occurrence of these sizes.
Constituting nearly 20%, microdeletions (≤ 20 bp)
generally rank among the most common pathological
human gene lesions [14]. Though most of the MED12
deletions were not larger than 20 bp, these cases do
not fit with the length distribution as reported for
“typical” microdeletions in the literature: Germ-line
Table 1 Details of 70 MED12 deletions analyzed
Diagnosis/Location Deletion Length (bp) of the deletion Reference
Uterine Leiomyoma c.117_152del 36 [8]
Uterine Leiomyoma c.118_159del 42 [8]
Uterine Leiomyoma c.121_135del 15 [8]
Uterine Leiomyoma c.131_145del 15 [8]
Uterine Leiomyoma c.137_151del 15 [8]
Uterine Leiomyoma c.136_153del 18 [8]
Uterine Leiomyoma c.121_132del 12 [8]
Uterine Leiomyoma c.124_137del 14 [8]
Uterine Leiomyoma c.149_163del15 15 [6]
Uterine Leiomyoma c.122_148del27 27 [6]
Uterine Leiomyoma c.103_138del36 36 [4]
Uterine Leiomyoma c.105_119del15 15 [4]
Uterine Leiomyoma c.106_108del3 3 [4]
Uterine Leiomyoma c.110_118del9 9 [4]
Uterine Leiomyoma c.112_138del27 27 [4]
Uterine Leiomyoma c.114_138del25insA 25ins1 [4]
Uterine Leiomyoma c.115_141del27 27 [4]
Uterine Leiomyoma c.116_122del7insC 7ins1 [4]
Uterine Leiomyoma c.116_154del39 39 [4]
Uterine Leiomyoma c.118_119insCGGCCTTGA 2ins9 [4]
Uterine Leiomyoma c.121_138del18 18 [4]
Uterine Leiomyoma c.122_157del36 36 [4]
Uterine Leiomyoma c.123_134del12 12 [4]
Uterine Leiomyoma c.126_140del15 15 [4]
Uterine Leiomyoma c.128_145del18 18 [4]
Uterine Leiomyoma c.129_131del3 3 [4]
Uterine Leiomyoma c.133_150del18 18 [4]
Uterine Leiomyoma c.138_152del15 15 [4]
Uterine Leiomyoma c.141_161del21 21 [4]
Uterine Leiomyoma IVS1-5_130del36 36 [4]
Uterine Leiomyoma IVS1-5_137del43 43 [4]
Uterine Leiomyoma IVS1-1_139del41 41 [4]
Uterine Leiomyoma c.121_138del18 18 [7]
Leiomyosarcoma (metastasis, small intestine) c.133_144del12 12 [7]
Uterine Leiomyoma c.123_134del12 12 [5]
Uterine Leiomyoma c.112_144delinsCTG 33ins3 [10]
Uterine Leiomyoma c.126_143del 18 [10]
bizarre Leiomyoma c.121_138del 18 [10]
Uterine Leiomyoma IVS1-4_114del 19 [10]
Uterine Leiomyoma c.126_134del9 9 [9]
STUMP c.122_148del27 27 [9]
Uterine Leiomyoma c.122_151del30 30 [11]
Uterine Leiomyoma IVS1-4_138del43 43 [11]
Leiomyoma of the ovary c.126_137del12 12 [11]
Leiomyoma of the kidney c.110_136del27 27 [11]
Leiomyosarcoma of the retroperitoneum c.133_144del12 12 [11]
Uterine Leiomyoma c.109_117del9 9 unpublished data
Markowski et al. Molecular Cytogenetics 2013, 6:23 Page 3 of 9
http://www.molecularcytogenetics.org/content/6/1/23
Table 1 Details of 70 MED12 deletions analyzed (Continued)
Uterine Leiomyoma c.110_118del9 9 unpublished data
Uterine Leiomyoma c.118_136del19insC 19ins 1 unpublished data
Uterine Leiomyoma c.120_122del3 3 unpublished data
Uterine Leiomyoma c.120_122del3 3 unpublished data
Uterine Leiomyoma c.120_125del6 6 unpublished data
Uterine Leiomyoma c.120_125del6 6 unpublished data
Uterine Leiomyoma c.122_148del27 27 unpublished data
Uterine Leiomyoma c.122_160del39 39 unpublished data
Uterine Leiomyoma c.123_152del30 30 unpublished data
Uterine Leiomyoma c.125_160del36 36 unpublished data
Uterine Leiomyoma c.125_160del36 36 unpublished data
Uterine Leiomyoma c.126_131del6 6 unpublished data
Uterine Leiomyoma c.126_140del15 15 unpublished data
Uterine Leiomyoma c.126_143del18 18 unpublished data
Uterine Leiomyoma c.133_150del18 18 unpublished data
Uterine Leiomyoma c.135_149del15 15 unpublished data
Uterine Leiomyoma c.136_150del15 15 unpublished data
Uterine Leiomyoma c.146_166del21 21 unpublished data
Uterine Leiomyoma c.147_161del15 15 unpublished data
Uterine Leiomyoma c.131_136del6 6 unpublished data
Uterine Leiomyoma IVS1-2_133del36 36 unpublished data
Uterine Leiomyoma c.136_153del18 18 unpublished data
Uterine Leiomyoma c.126_137del12 12 unpublished data
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Database (www.hgmd.org) have been analyzed by Ball et al.
[14]: In general, a decreasing frequency of microdeletions
with length was noted with more than 70% of the deletions
ranging between 1 and 5 base pairs. In contrast, the lengths
of the MED12 deletions observed in smooth muscle
tumors clustered between 2 and 43 bp and thus in many
cases the length of the deletions even exceeded the range
as defined for germline microdeletions (≤ 20 bp). These
differences may point to different mechanisms favoring
the occurrence of both types of deletions. As a mechanismFigure 1 Assignment of MED12 to Xq13. The gene structure with exons
Bottom line: Sequence of the region affected by deletions. The start of exoto explain the “typical” microdeletions slippage; mutagen-
esis removing mono-, di- or trinucleotide repeats has been
proposed [14,15]. In case of MED12, no evidence for a
mechanism that simply removes short repeats has been
obtained from the present analysis.
As to an alternative mechanism, it seems reasonable
to speculate that the deletions are due to non-B DNA
structures within the hotspot region. These structures
like cruciform, triplex, quadruplex, hairpin, or left-handed
Z-DNA conformations adopted at repeat sequences
can favour e.g. the occurrence of mutations like(rectangles) and introns corresponds to the NCBI Map Viewer [12].
n 2 is indicated by an arrow.
Figure 2 Lengths and positions of 70 MED12 deletions from own unpublished cases and cases reported in the literature (c.f. Table 1).
Each individual deletion seen in one smooth muscle tumor is given by a horizontal purple line. Bar on top of the illustration gives the segment
affected by deletions in these tumors. Numbers correspond to nt. of the coding transcript.
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[16]) as well as chromosomal translocations [17]. In
general, non-B DNA structures are considered as major
determinants of genomic rearrangements in human
diseases [18,19]. The pattern of breakpoint distributionFigure 3 Distribution of the lengths of the individual deletions highli
links columns with multitudes of 3 to illustrate that among the latter cases
underrepresented.over the affected region speaks in favour of such a
hypothesis. We were able to show that one cluster of
the deletion breakpoints is located within the center of
a putative stem-loop structure with a second cluster
downstream of the stem. In contrast, the sequencesghting a strong preference of multiples of 3 bp. Dashed line
those with deletions of 21, 24, 30, and 33 bp appear to be
Figure 4 A: For detailed analysis the MED12 segment affected by deletions was upstream and downstream extended by seven and six
bp, respectively each and then subdivided into subsegments of five nt. each. For illustration, these 5 nt. sliding windows are shown in pink
and green, respectively. B: Folded structure of the DNA-segment covering the MED12-deletions seen in uterine smooth muscle tumors. For
prediction the DNA segment affected by deletions (c.f. Figures 1 and 2) has been extended by seven and six nt., respectively, on both sides. Of
the predicted structures by m-fold that with the lowest free energy (given as kcal/mol) is given. For analyses of non-randomly distribution,
breakpoints within the five subsegment nt.-windows are corresponding to A. Breakpoints within each subsegment are given by triangles.
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frequency of deletion breakpoints. A similar clustering
of deletion breakpoints within or near predicted non-Bstructures recently has been reported for deletions of
human mitochondrial DNA [20]. Certainly, it cannot be
ruled out that a deviation from the orthodox right-handed
Figure 5 Detailed analysis of the breakpoint distribution within and around the stem-loop structure predicted in the centre of the
MED12 deletion DNA segment. A: The DNA segment containing the central folded structure (c.f. Figure 4B) is given as a linear DNA strand.
B: same segment as given in A shown as folded structure. Purple triangles: 5′ breaks, blue triangles: 3′ breaks.
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the folded structure does not explain the hypermutability
of that MED12 segment in smooth muscle tumors. On
the other hand, the enormously high frequence of such
deletions points to factors besides pure selection favouring
this type of molecular alteration. Yet unknown links of
folded DNA to its specific functions and behaviour as
e.g. particular recombination systems might explain
the patterns of MED12 deletions as demonstrated herein.
For prokaryotes, the participation of folded DNA in a
number of processes is well documented (for review see
[21]) and in eukaryotes as well, non-B DNA structures
seem to serve, at least temporarily, important physio-
logical functions. Leiomyomas are the most frequent
symptomatic human tumors at all and the reasons for this
frequent occurrence are not understood, yet. Naturally
occurring non-canonical DNA structures have been shown
to be prone to intrinsic mutagenicity in other types of
mammalian tumors as e.g. Burkitt’s lymphoma and murine
plasmocytomas [22,23]. In case of gross chromosomal
rearrangements, Imagaki et al. [24] were able to elucidate
the mechanisms by which such unusual DNA confirma-
tions can be cut finally resulting in translocations, deletions,
or inversions. To the best of our knowledge, the present
study is the first attempt to trace back the highly frequent
genetic alterations of MED12 to particular DNA-structures.
The non-canonical DNA structure itself as well as the
mechanisms leading to breakage and reunion may beintrinsically driven or depend on unknown secondary
factors. However, we feel that these initial data warrant
further interest. In the future, experimental methods based
on cloned fragments containing the deletion hotspot may
allow more detailed analyses of the relevant mechanisms.
Conclusions
Uterine fibroids are the most frequent symptomatic human
tumors at all. Frequently, these tumors display mutations
affecting the gene encoding mediator subcomplex 12
(MED12). In some of these cases MED12 is affected by
particular deletions major characteristics of which we have
addressed in the present paper. Interestingly, the non-
random distribution of breakpoints within the deletion
hotspot region may point to a role of non-canonical DNA
structures for the occurrence of these mutations and the




Of the MED12 deletions analyzed herein 24/70 are from
unpublished cases sequenced for MED12 mutations. All
samples were taken initially for diagnostic purposes and
de-identified prior to their use in the present study
following the rules of the Helsinki-declaration. Written
informed consent was obtained from all patients and
the study was approved by the local ethics committee
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cases were taken from the literature (c.f. Table 1).
DNA isolation
DNA from frozen tissue samples was isolated using the
QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) and
DNA from FFPE tissue samples was isolated using the
QIAamp DNA FFPE Tissue Kit (Qiagen) on a QIACube
(Qiagen) according to the manufacturer’s instructions.
PCR and sequencing
For PCR amplification 1000 ng of genomic template DNA
were used. Primers to amplify the desired human PCR
fragment of the genomic template DNA were those
recently described [4]. Subsequently, PCR-products were
separated by agarose gel-electrophoresis and the desired
DNA-fragments/-bands were extracted by a QIAquick
Gel Extraction Kit (Qiagen) using a QIACube (Qiagen)
according to manufacturer’s instructions. DNA-sequencing
of the purified PCR-products was performed by GATC
Biotech (GATC Biotech, Konstanz, Germany).
Analyses of DNA structures
For the analyses of DNA structures the m-fold web server
software for DNA strands [25] was used. Folding was
predicted according to the following parameters: folding
temperature: 37°C, NA+: 1.0M, Mg++: 0.0M. Of the
predicted structures that with the lowest free energy
(ΔG, expressed as kcal/mol) was used for further analyses.
In addition, for prediction of non-B DNA structures the
non–B DB [26,27] search tool has been used.
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